Literature DB >> 9204244

Nephrocalcinosis.

U S Alon1.   

Abstract

The routine use of ultrasonography has resulted in an explosion in the number of conditions reported to be associated with nephrocalcinosis. It has also been increasingly recognized that urolithiasis and nephrocalcinosis can coexist in the same patient. The two conditions most commonly associated with nephrocalcinosis in childhood are the use of furosemide in infancy and the treatment of patients with hypophosphatemic rickets with phosphate and vitamin D preparations. Although originally thought to be related to hypercalciuria, more recent studies in humans and research animals indicate a multifactorial etiology for furosemide-related nephrocalcinosis. In patients with hypophosphatemic rickets, it seems that the dose of phosphate and in particular the development of secondary hyperparathyroidism play a central role in the development of nephrocalcinosis. Among the entities recently reported to be associated with nephrocalcinosis are some that characteristically include Fanconi's syndrome. These findings dispute the previous teaching of lack of renal calcifications in this syndrome, which involves proximal renal tubular acidosis. The diagnosis of nephrocalcinosis requires a metabolic work-up to identify the offending factor. When identified, appropriate intervention should be instituted.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204244

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  9 in total

1.  An unusual cause of acute renal failure in a patient with surgical hypoparathyroidism: nephrocalcinosis.

Authors:  Gülay Koçak; Erdem Koçak; Alper Azak; Hatice Unverdi
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

2.  Paracellin-1 gene mutation with multiple congenital abnormalities.

Authors:  Mehmet Türkmen; Belde Kasap; Alper Soylu; Ece Böber; Martin Konrad; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2006-08-22       Impact factor: 3.714

3.  Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

Review 4.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

5.  Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.

Authors:  Uri S Alon; Roshanak Monzavi; Marc Lilien; Majid Rasoulpour; Mitchell E Geffner; Ora Yadin
Journal:  Pediatr Nephrol       Date:  2003-01-18       Impact factor: 3.714

Review 6.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Vitamin D deficiency in surgical congenital heart disease: prevalence and relevance.

Authors:  James Dayre McNally; Kusum Menon
Journal:  Transl Pediatr       Date:  2013-07

8.  Incomplete distal renal tubular acidosis with nephrocalcinosis.

Authors:  Joon Seok Choi; Chang Seong Kim; Jeong Woo Park; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Chonnam Med J       Date:  2011-12-26

Review 9.  Diagnostic examination of the child with urolithiasis or nephrocalcinosis.

Authors:  Bernd Hoppe; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-12-23       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.